PT Multi Medika Internasional Tbk (IDX:MMIX)
Indonesia · Delayed Price · Currency is IDR 745.00
+5.00 (0.68%)
Last updated: Aug 12, 2026, 2:54 PM WIB
IDX:MMIX Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 193,115 | 201,472 | 191,991 | 175,134 | 175,094 | 181,842 | |
Revenue Growth | -12.44% | 4.94% | 9.63% | 0.02% | -3.71% | 2965.83% |
Cost of Revenue | 77,626 | 79,782 | 81,686 | 71,832 | 84,014 | 114,249 |
Gross Profit | 115,489 | 121,690 | 110,305 | 103,302 | 91,080 | 67,593 |
Selling, General & Admin | 77,971 | 82,679 | 90,276 | 75,182 | 58,832 | 31,226 |
Other Operating Expenses | 7,836 | 7,622 | 651.48 | 2,642 | 948.51 | 2,934 |
Operating Expenses | 85,807 | 90,301 | 90,928 | 77,824 | 59,780 | 34,160 |
Operating Income | 29,682 | 31,390 | 19,377 | 25,479 | 31,300 | 33,433 |
Interest Expense | -434.11 | -1,138 | -2,864 | -1,293 | -678.56 | -883.14 |
Interest & Investment Income | 81.71 | 108.83 | 740.76 | 130.79 | 84.68 | 18.33 |
Currency Exchange Gain (Loss) | 121.31 | 122.64 | 50 | 37.74 | - | 4.2 |
Other Non Operating Income (Expenses) | -22,463 | -22,671 | -15,524 | -2,826 | -200.11 | -360 |
Pretax Income | 6,989 | 7,813 | 1,779 | 21,528 | 30,506 | 32,213 |
Income Tax Expense | 1,942 | 2,574 | 572.53 | 5,015 | 6,838 | 7,168 |
Net Income | 5,047 | 5,239 | 1,207 | 16,513 | 23,668 | 25,045 |
Net Income to Common | 5,047 | 5,239 | 1,207 | 16,513 | 23,668 | 25,045 |
Net Income Growth | -32.47% | 334.02% | -92.69% | -30.23% | -5.50% | 1674.33% |
Shares Outstanding (Basic) | 4,800 | 4,800 | 4,800 | 3,456 | 4,001 | 3,280 |
Shares Outstanding (Diluted) | 4,800 | 4,800 | 4,800 | 3,456 | 4,001 | 3,280 |
Shares Change | -0.21% | 0.00% | 38.90% | -13.62% | 21.98% | - |
EPS (Basic) | 1.05 | 1.09 | 0.25 | 4.78 | 5.92 | 7.64 |
EPS (Diluted) | 1.05 | 1.09 | 0.25 | 4.78 | 5.92 | 7.64 |
EPS Growth | -32.33% | 334.01% | -94.74% | -19.23% | -22.53% | - |
Free Cash Flow | 15,285 | 45,842 | -124,593 | -110,023 | -41,549 | 4,708 |
Free Cash Flow Per Share | 3.18 | 9.55 | -25.95 | -31.84 | -10.38 | 1.44 |
Gross Margin | 59.80% | 60.40% | 57.45% | 58.98% | 52.02% | 37.17% |
Operating Margin | 15.37% | 15.58% | 10.09% | 14.55% | 17.88% | 18.39% |
Profit Margin | 2.61% | 2.60% | 0.63% | 9.43% | 13.52% | 13.77% |
Free Cash Flow Margin | 7.92% | 22.75% | -64.89% | -62.82% | -23.73% | 2.59% |
EBITDA | 111,097 | 113,501 | 26,516 | 29,320 | 32,081 | 33,571 |
EBITDA Margin | 57.53% | 56.34% | 13.81% | 16.74% | 18.32% | 18.46% |
D&A For EBITDA | 81,415 | 82,111 | 7,139 | 3,841 | 780.69 | 138.03 |
EBIT | 29,682 | 31,390 | 19,377 | 25,479 | 31,300 | 33,433 |
EBIT Margin | 15.37% | 15.58% | 10.09% | 14.55% | 17.88% | 18.39% |
Effective Tax Rate | 27.79% | 32.95% | 32.17% | 23.30% | 22.41% | 22.25% |
Advertising Expenses | - | 12,853 | 22,246 | 25,601 | 28,176 | 8,517 |